Warner Chilcott, Mylan Deal OK'd In Birth Control IP Row

Law360, New York (August 5, 2013, 8:37 PM EDT) -- A New Jersey federal judge Monday greenlighted a settlement agreement between pharmaceutical giant Warner Chilcott Co. LLC and generics maker Mylan Inc. in Warner Chilcott’s suit over Mylan’s plans for a generic version of its birth control drug Loestrin.

The defendants have agreed that their plans to sell a generic version of Warner Chilcott’s Loestrin would infringe the claims it had asserted against them over U.S. Patent Number 5,552,394, U.S. District Judge Joel A. Pisano said in his order.

The company had accused Mylan of submitting...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.